文献速递分子诊断临床微生物

Xpert MTB/RIF Ultra在低流行地区肺结核诊断中的增益价值

Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting.
PubMed 文献 · J Clin Microbiol · 2019-01-30

该研究在瑞士洛桑低结核负担地区纳入196例疑似肺结核患者,比较Xpert MTB/RIF与Ultra对呼吸道标本的诊断性能。以培养为金标准,Ultra总敏感度95.8%高于Xpert的82.9%,涂阴标本敏感度91.7%高于66.7%,两者特异度相近。Ultra半定量结果与涂片抗酸杆菌负荷正相关。

要点

  • 低流行地区Ultra总敏感度95.8%,高于Xpert的82.9%。
  • 涂阴标本Ultra敏感度91.7%,明显高于Xpert的66.7%。
  • Ultra半定量结果与涂片抗酸杆菌负荷正相关。

核心结论

  • 在低结核流行地区,Ultra较Xpert对肺结核诊断敏感度更高。
  • Ultra半定量结果与抗酸杆菌负荷相关,有助于评估患者传播潜力。

主要发现

  • 全部培养阳性标本中,Xpert敏感度82.9%(39/47),Ultra敏感度95.8%(45/47)。
  • 涂阳标本中两者敏感度均为100%(23/23);涂阴标本中Xpert为66.7%(16/24),Ultra为91.7%(22/24)。
  • 以培养为金标准,Xpert特异度97.3%(145/149),Ultra特异度96.64%(144/149)。
  • Ultra结果为「trace」的患者均经临床和微生物培养诊断为活动性结核。
  • Xpert和Ultra的半定量结果均与抗酸杆菌检测半定量结果正相关。

关键数值与推荐

  • 涂阴标本中Ultra敏感度91.7%(22/24),Xpert为66.7%(16/24)。
  • 全部培养阳性标本中Ultra敏感度95.8%(45/47),Xpert为82.9%(39/47)。

临床怎么用

  • 在低流行地区,对涂阴疑似肺结核患者可优先考虑Ultra以提高检出率。
  • Ultra半定量结果可用于辅助评估患者的传播风险。

局限性

  • 研究为单中心、样本量196例,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Xpert MTB/RIF (Xpert) for direct molecular detection of Mycobacterium tuberculosis and rifampin resistance from clinical specimens has dramatically improved the diagnosis of tuberculosis (TB). Xpert MTB/RIF Ultra (Ultra) is proposed as a substitute of Xpert with increased sensitivity and improved rifampin resistance detection. We evaluated the diagnostic performance of Ultra and Xpert for pulmonary TB diagnosis in a low-TB-burden setting. Performance of Ultra and Xpert were compared to culture on respiratory specimens from patients with suspected pulmonary TB (November 2016 to August 2018; n = 196) in Lausanne (Switzerland). Clinical data were used to investigate discrepant results. Correlation between semiquantitative result of Ultra and smear microscopy status for the detection of acid-fast bacilli (AFB) was established. The sensitivities of Xpert and Ultra were 82.9% (39/47) and 95.8% (45/47), respectively, when considering all culture-positive specimens, 100% (23/23) for both assays on smear-positive specimens, and 66.7% (16/24) and 91.7% (22/24) on smear-negative specimens. Using culture as gold standard, the specificities of Xpert and Ultra were 97.3% (145/149) and 96.64% (144/149), respectively. All the patients with Ultra-positive results with the new category "trace" were diagnosed with active TB based on clinical findings and microbiological culture. The semiquantitative results of both Xpert and of Ultra positively correlated with the semiquantitative result of AFB detection. Our data support an increased sensitivity of Ultra compared to Xpert in a low-prevalence setting. Correlation between the Ultra semiquantitative result and AFB burden can help in evaluating a patient's transmission potential.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Opota O, Zakham F, Mazza-Stalder J, et al. Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting. J Clin Microbiol. 2019. PMID: 30541937. doi:10.1128/JCM.01717-18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。